VERO BIOTECH

vero-biotech-logo

Vero Biotech is a biopharmaceutical company focused on the design, development, and commercialization of next-generation products to address the unmet medical needs of patients with a variety of pulmonary and cardiac diseases. They are currently developing inhaled nitric oxide (NO) products for use in both the hospital setting and for longer-term applications outside of the hospital setting. These products, which are based on our GeNOsylโ„ข drug delivery technology, are comprised of a single-use drug cassette and either a portable console or wearable controller. Its technology is designed to deliver NO safely for a variety of therapeutic indications and to provide clinicians with a solution that is more user-friendly than currently available NO delivery systems.

#SimilarOrganizations #People #Financial #Website #More

VERO BIOTECH

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Medical Pharmaceutical

Founded:
2006-01-01

Address:
Atlanta, Georgia, United States

Country:
United States

Website Url:
http://www.vero-biotech.com

Total Employee:
101+

Status:
Active

Contact:
3217852460

Email Addresses:
[email protected]

Total Funding:
234.64 M USD

Technology used in webpage:
OpenResty GoDaddy SSL


Similar Organizations

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

lucaspye-bio-logo

LucasPye BIO

A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.

pfizer-logo

Pfizer

Pfizer provides access to safe and effective and affordable medicines and health care services.

phasebio-pharmaceuticals-logo

PhaseBio Pharmaceuticals

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

prolocor-logo

Prolocor

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

tcr2-logo

TCR2

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuCโ„ข platform.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.


Current Advisors List

patrick-lally_image

Patrick Lally Board Member @ Vero Biotech
Board_member
2023-01-11

Current Employees Featured

brent-v-furse_image

Brent V. Furse
Brent V. Furse President & Chief Executive Officer @ Vero Biotech
President & Chief Executive Officer

john-maynard_image

John Maynard
John Maynard VP of New Product Development @ Vero Biotech
VP of New Product Development
2019-06-01

kurt-dasse_image

Kurt Dasse
Kurt Dasse Chief Executive Officer @ Vero Biotech
Chief Executive Officer

Investors List

petrichor-healthcare-capital-management_image

Petrichor Healthcare Capital Management

Petrichor Healthcare Capital Management investment in Venture Round - Vero Biotech

mvm-life-science-partners_image

MVM Life Science Partners

MVM Life Science Partners investment in Series E - Vero Biotech

runway-growth-capital_image

Runway Growth Capital

Runway Growth Capital investment in Debt Financing - Vero Biotech

Official Site Inspections

http://www.vero-biotech.com Semrush global rank: 13.8 M Semrush visits lastest month: 72

  • Host name: 114.65.197.35.bc.googleusercontent.com
  • IP address: 35.197.65.114
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Vero Biotech"

Vero Biotech - Funding, Financials, Valuation & Investors

Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.See details»

Home | Vero Bioscience

Dr. Eric Verdin CEO of the Buck Institute for Research on AgingSee details»

Vero Biotech - Crunchbase Company Profile & Funding

Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.See details»

VERO Biotech - LinkedIn

Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical ...See details»

Solutions - VERO Biotech

Broadest Transport Label for Inhaled Nitric Oxide GENOSYL® Delivery System approved for transport in ground, fixed-wing & rotary-wing. Proven to withstand the use environments of ground, fixed-wing, and rotary-wing transport. โ€ฆSee details»

VERO Biotech - Overview, News & Similar companies - ZoomInfo

Jun 19, 2023 View VERO Biotech (www.vero-biotech.com) location in Georgia, United States , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

Vero (Biotechnology) 2025 Company Profile: Valuation, Funding ...

Information on valuation, funding, cap tables, investors, and executives for Vero (Biotechnology). Use the PitchBook Platform to explore the full profile.See details»

Vero Biotech LLC - Drug pipelines, Patents, Clinical trials - Synapse

Jul 18, 2025 Explore Vero Biotech LLC with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 13 news, Disease Domain:Nervous System Diseases, Neoplasms, โ€ฆSee details»

Vero Biotech โ€“ Overview โ€“ Funding, Revenue & Growth โ€“ 2025

Vero Biotech LLC, an Atlanta, Georgia-based biotechnology company, closed a senior secured term loan of $50m. Runway Growth Capital provided the financing. Led by Brent V. Furse, โ€ฆSee details»

Home - VERO Biotech

GENOSYL ® Delivery System utilizes the known properties of nitric oxide and other oxides of nitrogen, namely N 2 O 4 (dinitrogen tetroxide) and NO 2 (nitrogen dioxide), to create a โ€œtanklessโ€ drug/device system that generates a โ€ฆSee details»

Vero Biotech Inc. - Executive Bio, Top Executies, and Transitions ...

Vero Biotech is a biopharmaceutical company focused on the design, development, and commercialization of next-generation products to address the unmet medical needs of patients โ€ฆSee details»

Leadership Team - VERO Biotech

© Copyright 2025 - VERO Biotech. All rights reserved. VERO Biotech and GENOSYL are registered trademarks of VERO Biotech Inc.See details»

VERO Biotech 2025 Company Profile: Valuation, Funding

Information on valuation, funding, acquisitions, investors, and executives for VERO Biotech. Use the PitchBook Platform to explore the full profile.See details»

Opportunities - VERO Biotech

Come and explore our cross-functional team where everyone is aligned and passionate behind the belief that we can achieve something life-changing and meaningful for patients, and have โ€ฆSee details»

Vero Biotech - Financial Details - Crunchbase

Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.See details»

Vero Biotech - Growth Outlook - Crunchbase

Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.See details»

What is the Brief History of Vero Biotech Company?

Jul 24, 2025 The history of Vero Biotech is marked by significant milestones, particularly with its advancements in inhaled nitric oxide (iNO) delivery systems. These achievements highlight โ€ฆSee details»

Annual Report on Vero Biotech's Revenue, Growth, SWOT Analysis ...

Aug 4, 2025 Trademark applications show the products and services that Vero Biotech is developing and marketing. Vero Biotech doesn't have any recent trademark applications, โ€ฆSee details»

VeroBIOTECH - Veroderm Medical Biotechnologies

VeroBIOTECH Veroderm Medical Technologies applied nanotechnology for wound care solutions, for acute & chronic wounds. VeroBIOTECH- Cell-based Solutions With our innovative RMP & โ€ฆSee details»

VERO Biotech Announces Expansion to Commercial Team

Jun 27, 2024 VERO welcomes Suzanne Hagin as VP of Commercial Operations & Marketing and Rebecca Van Doren as VP of Strategic Development ATLANTA, June 27, 2024 โ€” VERO โ€ฆSee details»

linkstock.net © 2022. All rights reserved